Skip to content

Genvinset HLA B27v5 CE-IVD/IVDR 

Key Features


Simple setup

Product Description



Genvinset® HLA B27v5 is a semi-automated in vitro diagnostic kit for HLA-B*27 group of alleles qualitative detection in genomic DNA extracted from whole blood, associated with ankylosing spondylitis predisposition, by Real-Time PCR using TaqMan® probes technology.

The major histocompatibility complex (MHC) is the genetic region that contains the most polymorphic loci of the human genome. It is involved in the mechanism of antigen presentation and, as such, defines the general immunological response.

Within the MHC, the allelic family HLA-B*27 is part of the HLA-B locus. The frequency of individuals carrying HLA-B*27 varies widely across populations, being approximately 7-9% in Caucasians.

Patients who can benefit from this determination are those referred by a specialist with clinical symptoms compatible with rheumatoid diseases such as ankylosing spondylitis, reactive arthritis, psoriatic arthritis or juvenile enthesitis related arthritis, and acute anterior uveitis.

The results of this test should not be the only ones on which the therapeutic decision is based and should be used as an aid in the diagnosis together with results of other markers of the disease.

Request Quotation


Product
SKU
Pack Size
Qty
Genvinset HLA B27v5 CE-IVD/IVDR
SKU
GVS-B2705-48
Pack Size
48 tests

Request Documentation


Genvinset HLA B27v5 CE-IVD/IVDR
GVS-B2705-48

Latest News


New Solution to Perform Specialities in Every Laboratory

Automatic multi-parameter random access system for immunoassays with ready-to-use monotest devices.

Emissions Report for January - June 2025

NEQAS Coagulation June 4th-5th

Eurobio Scientific are exhibiting at the NEQAS Coagulation event in Sheffield on June 4th and 5th.

Looking Ahead in ER+/HER2- Breast Cancer - Unpacking Long-Term Prognostic Factors

An interactive discussion shaped by real-world clinical insights!

Subscribe now!

Contact Us